Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer
PRIVATEOct 01, 2026
Position
Chief Executive Officer
Company
Emerald Clinical
Michael Stibilj
SingaporeBiotechnologyHealth Care
Description
Emerald Clinical Trials announced the appointment of Michael Stibilj as Chief Executive Officer, effective 1 October 2026. His leadership is expected to guide the company through its next phase of growth following a transformative year.
Company Information
Company
Emerald Clinical
Location
Singapore, Southeast Asia, Singapore
About
Emerald Clinical is a leading global clinical research organization founded in Asia-Pacific, driven by scientific expertise and operational excellence. With over 20 years of experience and more than 500 people managing 40 geographical locations throughout the Asia-Pacific region, the USA, and Europe, Emerald Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers for all trial phases, registration, and post-marketing trials.
Fundz sees it the moment Emerald Clinical changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.